RudaCure attended BioKorea 2021, held at COEX in Seoul, and used the opportunity to showcase its traitement de la sécheresse oculaire candidate RCI001 and traitement de la douleur pipeline RCI002 to major national and international entreprises pharmaceutiques and investisseurs.
Through divers networking sessions at the conference, l'entreprise engaged in active discussions on future research collaboration and technology licence opportunities.